The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genome-wide copy number analysis of circulating tumor cells from patients (pts) with metastatic breast cancer (MBC).
M. J. M. Magbanua
No relevant relationships to disclose
E. Sosa
No relevant relationships to disclose
R. Roy
No relevant relationships to disclose
L. Eisenbud
No relevant relationships to disclose
J. Scott
No relevant relationships to disclose
A. Olshen
No relevant relationships to disclose
D. Pinkel
No relevant relationships to disclose
H. S. Rugo
Research Funding - Veridex
J. W. Park
Honoraria - Veridex
Research Funding - BD Biosciences; Veridex